Akari Therapeutics PLC (AKTX)
1.30
+0.06
(+4.84%)
USD |
NASDAQ |
Nov 22, 16:00
1.30
0.00 (0.00%)
Pre-Market: 20:00
Akari Therapeutics Stock Buybacks (Quarterly): 0.133M for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.133M |
June 30, 2024 | -7.094M |
March 31, 2024 | -1.726M |
December 31, 2023 | -3.514M |
September 30, 2023 | 0.00 |
June 30, 2023 | -0.29M |
March 31, 2023 | -3.212M |
June 30, 2022 | 0.00 |
March 31, 2022 | -12.37M |
December 31, 2021 | -1.116M |
September 30, 2021 | -11.18M |
June 30, 2021 | -1.994M |
March 31, 2021 | 0.00 |
December 31, 2020 | -5.992M |
September 30, 2020 | 0.00 |
June 30, 2020 | -9.176M |
March 31, 2020 | -9.878M |
December 31, 2019 | -2.776M |
September 30, 2019 | -8.398M |
June 30, 2019 | -1.316M |
March 31, 2019 | -0.1577M |
Date | Value |
---|---|
December 31, 2018 | -0.1534M |
September 30, 2018 | -0.3466M |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | -15.67M |
September 30, 2017 | 0.00 |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | -75.00M |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | -3.454M |
September 30, 2014 | -0.2371M |
June 30, 2014 | 8.219M |
March 31, 2014 | -8.219M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-12.37M
Minimum
Mar 2022
0.133M
Maximum
Sep 2024
-3.899M
Average
-2.385M
Median
Stock Buybacks (Quarterly) Benchmarks
DBV Technologies SA | -0.007M |
Ascendis Pharma AS | -- |
Cellectis SA | 0.00 |
Adaptimmune Therapeutics PLC | 0.00 |
Biodexa Pharmaceuticals PLC | -- |